CDH2 and chronic myelogenous leukemia, BCR-ABL1 positive: The role of CDH2 in directing stem-cell fate, tumor-microenvironment interactions, and chemoresistance has been implicated in a wide variety of solid tumors and certain hematological malignancies such as CML.71